Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy

NCT05031975 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Irinotecan
DRUG: Temozolomide

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano